Connect Biopharma Limite...

NASDAQ: CNTB · Real-Time Price · USD
1.98
-0.07 (-3.41%)
At close: Aug 18, 2025, 2:24 PM

Connect Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-15.63M -59.38M -116.12M -204.94M
Depreciation & Amortization
660K 988K 1.01M 640.98K
Stock-Based Compensation
6.73M 3.26M 1.01M 1.41M
Other Working Capital
-12.83M 12.72M 6.78M -5.62M
Other Non-Cash Items
118K -2.28M -1.35M 6.91K
Deferred Income Tax
n/a n/a 3.37M 106.37M
Change in Working Capital
-15.49M 9.48M 7.16M 3.27M
Operating Cash Flow
-23.61M -47.93M -99.27M -85.57M
Capital Expenditures
-750K -294K -4.28M -7.46M
Cash Acquisitions
n/a 2.94M 79.16K 47.73K
Purchase of Investments
-15.45M -32.6M -113.7M -17.98M
Sales Maturities Of Investments
12.63M 105.19M 34.54M 20.1M
Other Investing Acitivies
123K -84K -79.16K -47.74K
Investing Cash Flow
-3.45M 75.16M -83.44M -5.34M
Debt Repayment
n/a -290K -222K -126K
Common Stock Repurchased
n/a n/a n/a -566K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 119K -19.12M
Financial Cash Flow
227K -246K -91.29K 206.66M
Net Cash Flow
-27.43M 27M -168.93M 109.42M
Free Cash Flow
-24.36M -48.22M -103.55M -93.03M